Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Diabetes In Control Publisher Steve Freed interviewed Dr. David D’Alessio, Associate Professor of Medicine, Division of Endocrinology, University of Cincinnati, and the Albert Vontz chair in Diabetes Research. Dr. D’Alessio helps us understand some of the newest research on GLP-1’s, how he uses these therapies in his own practice and …
Read More »Interview with David D’Alessio, MD; Internal Medicine-Endocrinology, Professor
What are the effects of using a GLP-1 drug when on the Atkins diet and a low-fat diet? Who are the best candidates for using a GLP-1 drug? Can GLP-1 drugs reduce apoptosis and increase betacell regeneration? Our publisher, Steve Freed, asks these questions and much more of Dr. David …
Read More »An Eye-Opening Interview with Steven Edelman, MD, PART 2
This week, we present the second half of our publisher Steve Freed’s interview with Dr. Steven Edelman at the recent ADA Scientific Sessions in San Diego. Steve Freed: One of the more exciting things I have read about is the extra eyelet effect on the GLP-1 compounds on the heart …
Read More »An Eye-Opening Interview with Steven Edelman, MD, Founder and Director, TCOYD
Our publisher, Steve Freed, sat down with Dr. Steven Edelman at the ADA Scientific Sessions in San Diego, and asked, “When should we add the GLP-1 drugs in the progression of diabetes?” and “How comfortable are you with the safety of the GLP-1 drugs?” … Steve Freed: Thanks for taking …
Read More »Dr. Vinik Answers Our Best Questions on GLP-1 Therapy
This week, after our publisher Steve Freed was able to connect up with Dr. Vinik again, we bring you more insight on the latest in GLP-1 therapy. I asked Dr. Vinik , “Who is the ideal type 2 patient for GLP-1 treatment?” and “Can GLP-1 drugs prevent apoptosis and regenerate …
Read More »Interview with Aaron I. Vinik, MD, PhD, FCP, MACP
One of the leading diabetes researchers in the world, Dr. Aaron I. Vinik leads the EVMS Strelitz Diabetes Center’s quest to cure diabetes. Internationally renowned for his research in the areas of hormone secreting tumors and the chronic complications of diabetes, Dr. Vinik has presented his work all over the world…. …
Read More »Editor’s Interview with Dr. Vivian A. Fonseca
Last month I had a chance to chat with Vivian A. Fonseca, MD, FRCP, Tulane University Medical Center, about the GLP-1 analogs….
Read More »Perspectives from Diabetes Thought Leaders on the Use of GLP-1 Agonists
Leading experts, Anne L. Peters, MD, Ralph A. DeFronzo, MD, Alan J. Garber, MD, PhD, Robert R. Henry, MD, Richard Bergenstal, MD, and others, share their thoughts on GLP-1 therapy….
Read More »